abrdn Healthcare Opportunities Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-05-30 11:35:00 ET
Summary
- The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.
- During the first quarter of 2025, we made several changes to the portfolio.
- Against a backdrop of lingering inflationary pressures and a relatively buoyant labour market, the US Fed maintained the target range for the federal funds rate at 4.25–4.50% during the quarter.
Fund performance
The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter.[1]...
Read the full article on Seeking Alpha
For further details see:
abrdn Healthcare Opportunities Fund Q1 2025 Commentary
Avantor Inc.
NASDAQ: AVTR
AVTR Trading
-0.87% G/L:
$7.965 Last:
3,445,809 Volume:
$7.96 Open:
AVTR Latest News
AVTR Stock Data
$7,609,053,826
673,633,081
0.13%
173
N/A
Biotechnology & Life Sciences
Healthcare
US
Radnor
